Site for A Multi-Center Prospective Randomized Controlled Trial Comparing the Safety and Effectiveness of prodisc C SK and prodisc C Vivo to Mobi-C Cervical Disc in the Treatment of Two-Level Symptomatic Cervical Disc Disease (SCDD)
Brief description of study
Research study to evaluate the safety and effectiveness of prodisc C SK and prodisc C Vivo versus Mobi-C (currently available on market).
Clinical Study Identifier: s18-00779
ClinicalTrials.gov Identifier: NCT04012996
Principal Investigator:
Themistocles Protopsaltis.
If you are registered as a volunteer, please log in to contact the study team/express interest in this study.